Clinical Trial Update: A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating regorafenib for metastatic bone sarcomas is active but not recruiting, including Ewing sarcoma, chondrosarcoma, osteosarcoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondroma
• Chondrosarcoma
• Cic-rearranged Sarcoma
• Ewing Sarcoma
• Osteosarcoma

Drugs mentioned

• Stivarga (regorafenib)

Snippet

Sponsor: UNICANCER | Conditions: Ewing Sarcomas, Chondrosarcomas | Phase 2 | Status: ACTIVE_NOT_RECRUITING